Search


Current filters:



Start a new search
Add filters:

Use filters to refine the search results.


Results 111-120 of 147 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2011Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b studyKotasek, D.; Tebbutt, N.; Desai, J.; Welch, S.; Siu, L.; McCoy, S.; Sun, Y.; Johnson, J.; Adewoye, A.; Price, T.
2011Diagnostic accuracy of adenosine stress cardiovascular magnetic resonance following acute ST-segment elevation myocardial infarction post primary angioplastyWong, T.; Leung, M.; Das, R.; Liew, G.; Williams, K.; Dundon, B.; Molaee, P.; Teo, K.; Meredith, I.; Worthley, M.; Worthley, S.
2010Phase III, randomized, open-label study of daily Imatinib Mesylate 400 mg versus 800 mg in patients with newly diagnosed, previously untreated chronic myeloid leukemia in chronic phase using molecular end points: Tyrosine Kinase Inhibitor Optimization and Selectivity StudyCortes, A.; Baccarani, M.; Guilhot, F.; Druker, B.; Branford, S.; Kim, D.; Pane, F.; Pasquini, R.; Goldberg, S.; Kalaycio, M.; Moiraghi, B.; Rowe, J.; Tothova, E.; de Souza, C.; Rudoltz, M.; Yu, R.; Krahnke, T.; Kantarjian, H.; Radich, J.; Hughes, T.
2010Functional activity of the OCT-1 protein is predictive of long-term outcome in patients with chronic-phase chronic myeloid leukemia treated with ImatinibWhite, D.; Dang, P.; Engler, J.; Frede, A.; Osborn, M.; Saunders, V.; Manley, P.; Zrim, S.; Hughes, T.
2011Phase 2 trial of romidepsin in patients with peripheral T-cell lymphomaPiekarz, R.; Frye, R.; Prince, H.; Kirschbaum, M.; Zain, J.; Allen, S.; Jaffe, E.; Ling, A.; Turner, M.; Peer, C.; Figg, W.; Steinberg, S.; Smith, S.; Joske, D.; Lewis, I.; Hutchins, L.; Craig, M.; Fojo, A.; Wright, J.; Bates, S.
2015Recent trends in early stage response to combination antiretroviral therapy in AustraliaMcManus, H.; Hoy, J.; Woolley, I.; Boyd, M.; Kelly, M.; Mulhall, B.; Roth, N.; Petoumenos, K.; Law, M.
2016Active foot synovitis in patients with rheumatoid arthritis: unstable remission status, radiographic progression, and worse functional outcomes in patients with foot synovitis in apparent remissionWechalekar, M.; Lester, S.; Hill, C.; Lee, A.; Rischmueller, M.; Smith, M.; Walker, J.; Proudman, S.
2010Influence of comorbidities on therapeutic progression of diabetes treatment in Australian veterans: a cohort studyVitry, A.; Roughead, E.; Preiss, A.; Ryan, P.; Ramsay, E.; Gilbert, A.; Caughey, G.; Shakib, S.; Esterman, A.; Zhang, Y.; McDermott, R.; Fadini, G.P.
2012Effects of biocompatible versus standard fluid on peritoneal dialysis outcomesJohnson, D.; Brown, F.; Clarke, M.; Boudville, N.; Elias, T.; Foo, M.; Jones, B.; Kulkarni, H.; Langham, R.; Ranganathan, D.; Schollum, J.; Suranyi, M.; Tan, S.; Voss, D.
2013The outcomes of patients with ESRD and ANCA-associated vasculitis in Australia and New ZealandTang, W.; Bose, B.; McDonald, S.; Hawley, C.; Badve, S.; Boudville, N.; Brown, F.; Clayton, P.; Campbell, S.; Peh, C.; Johnson, D.